Fore Capital’s Labcorp LH Stock Holding History

Fore Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,000	Closed	-$4.65M	–	54
2025 Q1	$4.65M	Buy	+20,000	New	+$4.85M	2.75%	7

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fore Capital's LH Position: Q2 2025 in Review

Fore Capital sold out of Labcorp (LH) in Q2 2025, closing a stake of 8,400 shares — an estimated $1.96M sold.

Fore Capital first reported a position in LH in Q4 2024 and held it in 2 quarters. The position peaked at $1.96M in Q1 2025. 974 funds tracked by Wall St. Rank hold LH as of Q2 2025.

Fore Capital reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
Fore Capital sold 8,400 Labcorp shares in Q2 2025, an estimated $1.96M.
Fore Capital first reported a position in Labcorp in Q4 2024 and held it in 2 quarters.
Fore Capital's Labcorp position peaked at $1.96M in Q1 2025.
974 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on Fore Capital's 13F filing for Q2 2025, filed 11 Aug 2025.